Bio

Generated by
Topline AI
Selim Rachidi is a seasoned pharmaceutical industry professional with 20+ years of experience in clinical trials, regulatory affairs, and clinical development. He has held various leadership positions, including Lead Compliance Policy and Functional Advising Center of Excellence at Novartis Pharmaceuticals, USA. He is also an Adjunct Assistant Professor at Rutgers University and has taught clinical operations courses. Rachidi holds a Master's degree in Health Technology from the University of Pharmacy, Montpellier, France, and a Graduate Diploma in Statistics and Methodology in Clinical Trials from the School of Medicine, Paris, France.

Credentials

  • HealthCare Compliance Certification
    Seton Hall University
    Jun, 2012
    - Nov, 2025

Experience

    • Advisory Board Member - Ithaca College - Cybersecurity Program
      • Oct 2022 - Present

    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Lead Compliance Policy & Functional Advising Center of Excellence
      • Mar 2015 - Present

      Neuroscience, Cardiovascular, Ophthalmology, Immunology, Dermatology & RespiratoryEthics Risk & ComplianceHealthcare ComplianceClinical Development Medical AffairsHealth Care System Access & Engagement C-suite levelMedical/Commercial CollaborationResearch Collaboration Implementation ScienceGrant, Sponsorship & other funding Clinical Trials Interactions with healthcare professionals & government officialsCode of ConductAnti-BriberyStark Law & FCAConflict Of InterestAudit, Monitoring & InvestigationEnterprise Risk Assessment & ManagementManagement Experience

    • Head Integrity & Compliance, Americas
      • Mar 2013 - Mar 2015

      Ethics & ComplianceHealthcare ComplianceP3 Promotional PracticesInteractions with health Care ProfessionalsCode of ConductAnti-Bribery• Built a strong integrity & compliance programs with a team of local compliance officers• Collaborated and developed an outstanding working relationship with the business, Internal Audit & Speak-up Office in reviewing & addressing a wide range of regional & country specific issues• Conducted a review of the business compliance policy: proposed & implemented enhancements to the policy• Established a strong compliance network with Pharma Centers of Excellence. This resulted in Pharma supporting OTC Americas in the Fair Market Value process, Sunshine act initiative and other key OTC priorities• Collaborated with regional leadership/GMs and their respective functions (QA, Tech ops, R&D, HR etc..) to coordinate all the compliance initiatives and training across the Americas regions.• Collaborated with each country (OU GM, local compliance officer and local leadership team) to Identify the country top 5 risks and aligned on the appropriate mitigation & monitoring steps• Enhanced the visibility of the Compliance function & conducted frequent market visit, onboarding the country OU GM and the local country leadership,• Performed a resource need and a skill set need assessments in each country. Recommended to upgrade the skill set of certain local compliance officers and worked with the country GM to identify the right talent to drive change.• Successfully supported and passed all internal audits in the Americas region (Colombia , Venezuela, Canada, & Global I&C audits)

    • Director, Clinical Operations
      • Jan 2007 - Feb 2013

      CLINICAL THERAPEUTIC AREA EXPERIENCE:• Pain: acute & chronic indications in: knee & hip replacement, dental pain, knee & hand OA. Phase 1 to 3. Multiple formulations: IV, oral, gel & iontophoretic patch• Diabetes: metformin & glyburide in Phase 1 & 2. HbA1c devices, oral & foot care with OTC products.• G.I.: day & night time heartburn Phase 3 studies for a PPI Rx to OTC switch.• Immunology: biologic agent in renal transplant indication• C.V.: fenofibrate & statins in different phases and in a Rx to OTC switch• H.R.T.: estrogen & progesterone patches in Phase 1 & 2• Pediatric studies: PK studies in Cough & Cold• Rx to OTC Switches: statin & heartburn programs: with Phase 3, label comp & actual use studies• Size of the programs: from <100 subjects to 2,000 subjects with cost from $1MM to $40 MM

    • Associate Director, Clinical Operations
      • Mar 2004 - Dec 2006

    • Adjunct Assistant Professor
      • Feb 2013 - Nov 2022
      • New Jersey

      Teach a 3-credit Clinical Operations course (Master in Clinical Trial Sciences)

    • Adjunct Assistant Professor
      • 2011 - Jun 2011
      • NJ

      Teach a 3-credit Clinical Operations course (Master in Clinical Trial Sciences)

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Sr Clinical Manager
      • Mar 2003 - Feb 2004

    • Clinical Manager
      • Apr 2002 - Mar 2003

    • Sr CRA
      • 2000 - 2002

    • Sr CRA
      • 1998 - 2000

      UPSA - Bristol-Myers Squibb in Paris France

    • CRA
      • 1996 - 1998

      Laboratoire Fournier in Dijon, France

Education

  • University of Pharmacy, Montpellier, France
    Master, Health Technology - University of Pharmacy, Montpellier, France
  • School of Medicine, Paris, France
    Graduate Diploma in statistics and methodology in clinical trials

Services

Industry Focus. “Pharmaceutical and Healthcare”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

Performance Reviews

Track how others rated your recent work.

Highlights

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles